ORIENT BIO Inc. (KRX:002630)

South Korea flag South Korea · Delayed Price · Currency is KRW
544.00
-7.00 (-1.27%)
Apr 29, 2026, 3:30 PM KST
-60.00%
Market Cap 64.50B
Revenue (ttm) 59.09B
Net Income (ttm) -6.85B
Shares Out 118.57M
EPS (ttm) -57.81
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 432,145
Average Volume 587,792
Open 553.00
Previous Close 551.00
Day's Range 540.00 - 558.00
52-Week Range 513.00 - 1,994.00
Beta 0.19
RSI 43.64
Earnings Date n/a

About ORIENT BIO

ORIENT BIO Inc. operates in the bio-industry in South Korea and internationally. It engages in the production, export, import, and life science-related research and development of laboratory animals; and offers various equipment for research environment. The company also provides infrastructural solution; health checking; generic testing; molecular biological generic testing; generic transformation; phenotyping; preconditioning; surgical treatment; transgenic services; eggs and avian research; support services for husbandry tasks; diagnostic an... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1959
Employees 125
Stock Exchange Korea Stock Exchange
Ticker Symbol 002630
Full Company Profile

Financial Performance

In fiscal year 2021, ORIENT BIO's revenue was 52.02 billion, an increase of 39.79% compared to the previous year's 37.21 billion. Losses were -15.63 billion, 30.3% more than in 2020.

Financial Statements

News

There is no news available yet.